FDA Approves First Drug for Bone Marrow Disorder

By: Associated Press
By: Associated Press

WASHINGTON (AP) -- The Food and Drug Administration says it has approved the first drug for a rare disorder that causes red blood cells to build up inside patients' bone marrow.

Jakafi, a twice-a-day pill from Incyte Corp., was approved to treat myelofibrosis, which causes anemia, fatigue, pain and swelling of the spleen. The drug works by blocking two enzymes associated with the disease.

Jakafi is the first drug to reach the market from Wilmington, Delaware-based Incyte. The company partnered with Swiss drugmaker Novartis, which holds foreign marketing rights to the drug. Incyte shares rose 6 cents to $12.66 in morning trading.

The FDA reviewed the drug under its priority review program for important new therapies, which aims to clear drugs in six months instead of the usual 10.

Side effects reported in patients taking the drug included diarrhea, headache, dizziness and nausea.

Join the Conversation!

To comment, the following rules must be followed:

  • No Obscenity, Profanity, Vulgarity, Racism or Violent Descriptions
  • No Negative Community Comparisons
  • No Fighting, Name-calling, or Personal Attacks
  • Multiple Accounts are Not Allowed
  • Stay on Story Topic

Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.

Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Questions may be sent to comments@wsaw.com.
Please provide detailed information.
All comments must adhere to the WSAW.com discussion rules.

powered by Disqus
WSAW-TV 1114 Grand Ave. Wausau, WI 54403
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 133973483 - wsaw.com/a?a=133973483
Gray Television, Inc.